Feeding into the small intestine may reduce reflux and oxygen dips in fragile preterm infants

NCT ID NCT06534359

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This pilot trial tests whether feeding directly into the small intestine (transpyloric) is better than feeding into the stomach (gastric) for very preterm infants with bronchopulmonary dysplasia, a chronic lung condition. The study will measure how often babies have low oxygen levels and serious side effects, and whether the feeding method reduces acid reflux. Sixty infants born before 32 weeks will be randomly assigned to one of the two feeding methods for two weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transpyloric tube feeding (feeding into the small intestine) and gastric tube feeding (feeding into the stomach)

What this could lead to

If transpyloric feeding works better, it could offer a safer way to feed very preterm infants with lung disease, reducing reflux and dangerous drops in oxygen levels.

What could go wrong

This is a small pilot study with only 60 infants, so results may not apply to all babies. The feeding tube into the small intestine may cause its own complications, and the trial is not designed to prove long-term benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Colorado

    RECRUITING

    Denver, Colorado, 80218, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Children's Mercy Hospital

    NOT_YET_RECRUITING

    Kansas City, Missouri, 64108, United States

    Contact Phone: •••-•••-••••

  • Stanford University

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••